Cancer Genetics, Inc. Gains 49.05%
Wed, Feb 10, 2021 at 05:30 PM
Cancer Genetics, Inc. (CGIX:NASDAQ) soared at $8.6, a gain of 49%. On Tue 09 Feb 21, CGIX:NASDAQ hit a New 2-Week High of $5.77. The stock appeared on our News Catalysts scanner on Sat 06 Feb 21 at 01:03 PM in the 'INVESTOR UPDATE' category. From Tue 26 Jan 21, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Wed 20 Jan 21 at $5.95 with a volume of 8M+.
About Cancer Genetics, Inc. (CGIX:NASDAQ)
Cancer Genetics Inc is an early-stage diagnostics company which develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient.
Top 10 Gainers:
- Anchiano Therapeutics Ltd (ANCN:NASDAQ), 187.36%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 126.35%
- United States Antimony Corporation (UAMY:NYSEMKT), 82.56%
- Sundial Growers Inc. (SNDL:NASDAQ), 78.79%
- Tengasco, Inc. (TGC:NYSEMKT), 77.19%
- Torchlight Energy Resources, Inc. (TRCH:NASDAQ), 62.19%
- Tilray, Inc. (TLRY:NASDAQ), 50.91%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 50.53%
- AYRO (AYRO:NASDAQ), 50.2%
- Cancer Genetics, Inc. (CGIX:NASDAQ), 49.05%